Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Food and Drug Administration (FDA) says data from an ongoing safety review of oral bisphosphonates, such as Fosamax, prescribed for the treatment of bone loss, do not appear to be related to an increased risk of thigh fractures. However, the agency is telling health care professionals to be aware of a possible risk of atypical subtrochanteric femur fractures in patients using bisphosphonates.

The ongoing safety review was initiated in June 2008, following published case reports of this specific type of thigh fracture in patients with osteoporosis taking bisphosphonates. The agency says it will continue to study this issue along with a team of outside experts, which includes members of the American Society of Bone and Mineral Research Subtrochanteric Femoral Fracture Task Force.

Read the rest of this entry »

It seemed suspicious to the team of dentists at the University of Southern California (USC), the fact that so many patients treated at the university dental clinic were being diagnosed with osteonecrosis of the jaw, or ONJ. So dentists there pored through the records of more than 13,000 patients and found that 208 of them had been taking the osteoporosis drug Fosamax, and of those 208, four percent had ONJ.

Read the rest of this entry »

Osteoprosis poses a serious health risk for women. According to Natural News, women have a higher risk of dying from the bone condition than from breast cancer. But the treatment may be just as dangerous.

Fosamax is in a class of drugs called bisphosphonates (also called diphosphonates) that inhibit osteoclast action and the resorption of bone. It is one of the more popular choices for the treatment of osteoporosis. Natural News warns that Fosamax has been shown to increase the risk of ulcers, especially if taken with anti-inflammatory drugs. The publication also questions whether the medication actually strengthens the bone or makes it weaker.

Read the rest of this entry »

The Food and Drug Administration (FDA) is going to be taking another look at Fosamax and other bone building drugs because they could be causing irregular heartbeats in some patients.

Read the rest of this entry »